C-Rad AB Stocks

Established in 2004 and based in Uppsala, Sweden, C-Rad AB (publ) is a global innovator specializing in the development, manufacturing, and distribution of advanced systems designed for radiation therapy in cancer treatment. The company operates through its two core segments: Positioning and Imaging. Its extensive product portfolio features cutting-edge solutions such as Sentinel 4D CT, a laser-based optical surface scanning system. A significant portion of its offerings falls under the Catalyst family of surface image guided radiation therapy (SIGRT) solutions, including the foundational Catalyst 4D system; Catalyst HD, which enables online patient tracking both before and during stereotactic radiation therapy; Catalyst+ for high-precision patient positioning, managing intra-fraction motion, and respiratory gating; and Catalyst+ HD, which delivers these same capabilities for both conventional and stereotactic treatment methods. Further specialized products encompass Catalyst Tomo for enhanced positioning in tomotherapy and Catalyst PT for real-time tracking during particle therapy. Additionally, C-Rad provides Cyrpa laser positioning devices, cAccessory for automating the registration and validation of treatment accessories, and cPatient for contactless, automated patient identity verification. Beyond its products, the company offers crucial services, including installation, application training, and comprehensive after-sales support.